Nexgel (NXGL) EBITDA Margin Growth (3y) (2021 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 473.00 |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -1,105.00 |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 800.00 |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -71.00 |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | -1,411.00 |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 266.00 |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | -51.00 |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -284.00 |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 210.00 |
| 10 | Nexgel | 31,199.58 | -1.34 Mn | 819,000.00 | 20,377.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20,377.00 |
| Sep 30, 2025 | 15,786.00 |
| Jun 30, 2025 | 10,593.00 |
| Mar 31, 2025 | 17,736.00 |
| Dec 31, 2024 | 13,876.00 |
| Sep 30, 2024 | 15,529.00 |
| Jun 30, 2024 | 5,942.00 |
| Mar 31, 2024 | 12,596.00 |
| Dec 31, 2023 | 55,665.00 |
| Sep 30, 2023 | 17,095.00 |
| Jun 30, 2023 | 52,811.00 |
| Mar 31, 2023 | 6,966.00 |
| Dec 31, 2022 | 2,880.00 |
| Sep 30, 2022 | -20,835.00 |
| Mar 31, 2022 | 26,937.00 |
| Dec 31, 2021 | -2,347.00 |
| Sep 30, 2021 | 3,458.00 |